The U.S. Department of Justice found that UCLA’s David Geffen School of Medicine illegally considered race in admissions, intensifying federal oversight following the Supreme Court’s 2023 ban on race-conscious admissions. DOJ’s letter of findings says UCLA discriminated against White and Asian American applicants by favoring Black and Hispanic applicants using non-academic factors. Among the evidence cited, DOJ pointed to admitted-student GPA and test-score differences across groups in 2023 and 2024, including an example where admitted Black students had an average GPA of 3.72 compared with 3.84 for Asian Americans and 3.83 for White students. DOJ also flagged an application prompt asking applicants to describe whether they were part of a marginalized group and how that impacted them. UCLA said its process is based on merit and is reviewing the findings. The case escalates a broader DOJ campaign that includes investigations into other medical schools and heightened data collection demands for admissions compliance across selective institutions.